MADISON VALLEY MEDICAL CENTER
1. Target Overview & Investment Thesis
MADISON VALLEY MEDICAL CENTER is a 10-bed rural/critical access in MADISON, MT with $10.5M in net patient revenue and a -25.9% operating margin. The hospital serves a payer mix of 83.2% Medicare, 2.1% Medicaid, and 14.7% commercial.
Thesis: Turnaround. Our ML models identify $777K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -25.9% to -18.5% (+741bps).
| Net Revenue HCRIS | $10.5M |
| Current EBITDA COMPUTED | $-2.7M |
| Operating Margin COMPUTED | -25.9% |
| Occupancy HCRIS | 26.2% |
| Revenue / Bed COMPUTED | $1.0M |
| Net-to-Gross HCRIS | 99.3% |
| Distress Probability ML | 62.9% |
2. Market Context & Competitive Position
MT has 66 Medicare-certified hospitals with a median operating margin of -9.6%. The target's margin of -25.9% places it below the state median. Among 13 size-comparable peers (5-20 beds), the median margin is -9.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (5-20), prioritizing same-state peers. 13 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MADISON VALLEY MEDICAL CENTER (Target) | MT | 10 | $10.5M | -25.9% |
| GREAT FALLS CLINIC MEDICAL CEN | MT | 20 | $132.1M | 21.0% |
| HEALTHCENTER NORTHWEST | MT | 17 | $67.2M | 24.0% |
| BARRETT HOSPITAL AND HEALTHCAR | MT | 18 | $39.9M | -1.5% |
| CLARK FORK VALLEY HOSPITAL | MT | 16 | $25.9M | -14.6% |
| DEER LODGE MEDICAL CENTER | MT | 16 | $21.2M | -9.1% |
| BEARTOOTH BILLINGS CLINIC | MT | 10 | $18.4M | -6.6% |
| SHERIDAN MEMORIAL HOSPITAL | MT | 19 | $16.7M | -9.6% |
| LOGAN HEALTH CONRAD | MT | 20 | $16.0M | -19.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $777K (741bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $220K | +210bp | 18mo |
| Denial Rate Reduction | 12.0% | 6.5% | $210K | +200bp | 12mo |
| Cost to Collect | 4.5% | 2.5% | $210K | +200bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $128K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +9bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.7M |
| + RCM Uplift | +$777K |
| Pro Forma EBITDA | $-1.9M |
| Current Margin | -25.9% |
| Pro Forma Margin | -18.5% |
| WC Released (1x) | $402K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-4.2M | $-10.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-4.2M | $-12.5M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-3.8M | $-11.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-3.8M | $-13.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-4.6M | $-12.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-4.6M | $-15.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 83.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| Medium | Low occupancy | At 26.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 62.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 13 hospitals with 5-20 beds
- Same-state prioritization (n=19)
- Comp margins: P25=-14.6% / P50=-9.1% / P75=-1.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.